Find out more about the Healthy Heart Africa programme

This video provides more information on how we plan to tackle hypertension in Africa, working with our partners: AMPATH, AMREF Kenya, the Christian Health Association of Kenya, Jhpiego, Population Services Kenya, Mission for Essential Drugs and Supplies and Abt Associates.

Read more here


LabTalk is AstraZeneca’s science-focused blog where you can hear from scientists, researchers and academics discussing novel ideas, research and innovation.

Searching_for_the_rare_THM 31 October 2014

Searching for the EGFR mutation prospective gefitinib study

Nobel_Prize_II_THM 20 October 2014

Stimulating the next generation: the Nobel Prize Inspiration Initiative

A_neuroscience_vision_THM 16 October 2014

A Neuroscience Vision: Right Partner, Right Time, Right Place

Latest press releases

US FDA approves once-daily XIGDUO™ XR tablets for adults with Type 2 Diabetes
30 October 2014
AstraZeneca launches Healthy Heart Africa programme to address hypertension in Africa
28 October 2014
Lynparza™ (olaparib) receives positive CHMP opinion in the EU for the maintenance treatment of BRCA-mutated platinum sensitive relapsed ovarian cancer
24 October 2014
AstraZeneca strengthens partnership with the University of Cambridge
16 October 2014
Positive results from Phase IIb benralizumab study in severe asthma published in The Lancet Respiratory Medicine
9 October 2014
AstraZeneca updates on progress of oncology pipeline at ESMO 2014 congress
27 September 2014
MOVENTIG® (naloxegol) receives positive CHMP opinion in the EU for the treatment of adults with opioid-induced constipation
26 September 2014
IRESSA receives CHMP positive opinion to include blood based diagnostic testing in European label
26 September 2014
MedImmune and Cancer Research UK establish joint CRUK-MEDI Alliance Laboratory to develop new biologic cancer medicines
25 September 2014
Study showed AstraZeneca’s exenatide once-weekly suspension for autoinjection provided superior HbA1c reductions vs. twice-daily exenatide (Byetta®) in adults with type 2 diabetes
19 September 2014
FDA approves MOVANTIK™ (naloxegol) tablets C-II for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain
16 September 2014
AstraZeneca and Lilly announce alliance to develop and commercialise BACE inhibitor AZD3293 for Alzheimer’s disease
16 September 2014